This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hoeldtke, R. D. Articles by Hobbs, G. R. Search for Related Content PubMed PubMed Citation Articles by Hoeldtke, R. D. Articles by Hobbs, G. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Treatment of Orthostatic Hypotension with Midodrine and Octreotide¹

Department of Medicine (R.D.H., G.G.H., K.D.B.), and Departments of Community Medicine, Biostatistics, and Computer Science (G.R.H.), West Virginia University, Morgantown, West Virginia 26506-9159

Address all correspondence and requests for reprints to: Robert D. Hoeldtke, M.D., Ph.D., Department of Medicine, P.O. Box 9159, Morgantown, West Virginia 26506-9159.

The purpose of this study was to compare two treatments for orthostatic hypotension, midodrine (an adrenergic agonist), and octreotide (an SRIH analogue) to each other and to combination therapy. Sixteen patients participated. Our hypothesis was that the 2 drugs together would be more effective than either drug alone.

The effect of the drugs on the hemodynamic response to food ingestion was evaluated while patients were sitting. Midodrine (5 mg orally, 30 min before breakfast) increased mean blood pressure slightly (5–10 mm Hg, over 30 min) before the patients started eating, but it only partially reversed the hypotensive effect of food ingestion. The nadir in postprandial blood pressure after midodrine was 69 ± 4 mm Hg, not different from placebo (63 ± 5). Nevertheless, midodrine accentuated the response to sc octreotide (0.5 µg/kg). Fifteen minutes after octreotide administration to midodrine-pretreated patients, the average mean blood pressure was 115 ± 9 mm Hg, higher (P = .0095) than after octreotide given alone (102 ± 7).

Drug effects on orthostatic hypotension were assessed by measuring standing time (minutes before symptoms of hypotension or definite hypotension). In the absence of treatment, standing time was 3.5 ± 7 min; 1 h after 10 mg midodrine, 8.4 ± 2.7 min (P = .11); after 1.0 µg/kg octreotide, 13.2 ± 3.9 min (P = .0034 vs. no treatment); and after both drugs, 21.2 ± 5.5 min (P = .0002 vs. no treatment, P = .036 vs. octreotide only).

The combination of midodrine and octreotide is more potent than either drug alone.

This article has been cited by other articles:

				D Gupta and M D Nair Neurogenic orthostatic hypotension: chasing "the fall" Postgrad. Med. J., January 1, 2008; 84(987): 6 - 14. [Abstract] [Full Text] [PDF]

				R. E. Maser and M. J. Lenhard Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus: Clinical Manifestations, Consequences, and Treatment J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5896 - 5903. [Abstract] [Full Text] [PDF]

				C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach Hypertension, April 1, 2005; 45(4): 469 - 476. [Abstract] [Full Text] [PDF]

				C. J MATHIAS and J. R KIMBER Treatment of postural hypotension J. Neurol. Neurosurg. Psychiatry, September 1, 1998; 65(3): 285 - 289. [Full Text]